Immunohistochemistry: the immunohistochemistry results showed that all glioblastomas expressed wild-type IDH1-protein, which is in agreement with the new 2021 World Health Organization Classification of Tumors of the Central Nervous that indicates the grade 4 glioblastomas do not have the mutated form of the IDH gene. This evidence concerns the gene IDH1 and glioblastoma.